About Us

Forget what you thought you knew about NGS targeting workflows.

Molecular Loop brings elegant simplicity to targeted NGS.

Our Mission

We deliver targeted NGS technology that works and is easy to use. Our simple solutions will accelerate innovation and make genetic testing even more accessible. Easy on your staff. Simplifying the lab.

Molecular Loop’s patented technology was developed over many years to enable high-accuracy, ultra high-throughput NGS sequencing solutions for clinical applications and large-scale research projects. We specialize in developing production-grade chemistry that simplifies the workflow, reduces cost and time, significantly increases throughput, and delivers high-quality results. The technology has been used extensively in clinical studies and has a strong publication record.

Our Team

NGS veterans with battle-hardened and field-tested technology

Greg Porreca, Ph.D.

Co-founder, President & CEO

Eric Boyden, Ph.D.

Co-founder and Chief Scientific Officer

Pat Saunders

Chief Operating Officer

Lindsay Wold

Vice President of Sales

Vanessa Weisman


Jack Amaral

Senior Production Technologist

Joe Vieira

Head of Engineering

Kelly Glibas

NGS Sales Specialist

Danielle Bodnar

Senior NGS Sales Specialist

Arjun Patel

Bioinformatics Analyst

Marelize du Toit

Director of Product

Matt Parisi

VP of Operations

Joseph Juodvalkis

Lab Technician

Molecular Loop Technology Timeline

Initial publication of MIP technology for targeted NGS
Initial clinical user lauch of Good Start Genetics' first carrier screening offering
Publication of analytical validation of MIP technology for carrier screening
Good Start Genetics offers MIP-based carrier screening
Invitae acquires Good Start Genetics, including MIP technology
Molecular Loop acquires MIP technology from Invitae


Porreca, G. J., K. Zhang, J. B. Li, B. Xie, D. Austin, S. L. Vassallo, E. M. LeProust et al. “Multiplex amplification of large sets of human exons.” Nature methods 4, no. 11 (2007): 931-936.

Umbarger, M. A., C. J. Kennedy, P. Saunders, B. Breton, N. Chennagiri, J. Emhoff, V. Greger et al. “Next-generation carrier screening.” Genetics in Medicine 16, no. 2 (2014): 132-140.

Hallam, Stephanie, et al. “Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.” The Journal of Molecular Diagnostics 16, no. 2 (2014): 180-189.